#EPA2019 – presentation of the Company’s scientific and research projects as well as its generic portfolio during the most important event of European psychiatry

Celon Pharma S.A. representatives took part in the 27th European Congress of Psychiatry, EPA 2019, which was held from 6 to 9 April 2019 in Warsaw. Over 3,500 participants from all over the world took part in workshops, lectures and presentations devoted to the latest achievements in neuropsychiatry. The European Psychiatric Association is the biggest organisation of psychiatrists from all over Europe. Joint forces of the research and development department, as well as marketing and medicinal product sales departments, represented the Company on the stand during the exhibition part.

Both our innovative projects in the field of neuropsychiatry, raised great interest among the visitors of our stand during this year's conference. However, because of its sophistication, the clinical esketamine programme was the most frequently asked about by the visitors. We can observe a very positive reception of the project, among both European and Polish specialists. - dr Maciej Wieczorek, President of the Management Board at Celon Pharma S.A.